| (210) | Number of the EPO application | 17726073 |
| (220) | Filing date of the EPO application | 2017.05.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2021, 2021.11.17 |
| (110) | EPO patent number | 3458091 |
| (21) | Number of the application | e 2019 0356 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | BENDER Mark Harrath, US;
GAO Hong, US;
PATEL Bharvin Kumar, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); A61K 45/06 (2006.01.01); A61K 31/542 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.04.30 |
| (30) | Priority | 201662339363 P, 2016.05.20, US |
| (86) | International application | PCT/US2017/032790, 2017.05.16 |
| (87) | International publication | WO 2017/200969, 2017.11.23 |